Status:
COMPLETED
Real-life Experience of Tofacitinib in Patients With Treatment-Resistant Rheumatoid Arthritis
Lead Sponsor:
Umraniye Education and Research Hospital
Conditions:
Rheumatoid Arthritis
Treatment Adherence and Compliance
Eligibility:
All Genders
18-68 years
Brief Summary
The investigators aimed to present the efficacy and safety data for patients with RA who received tofacitinib therapy in outpatient clinics.
Detailed Description
This retrospective cohort study included 35 patients with rheumatoid arthritis who received tofacitinib therapy in rheumatology outpatient clinic between June 2015 and December 2019. Patients who rece...
Eligibility Criteria
Inclusion
- Patients who received tofacitinib due to unresponsiveness to ≥2 csDMARDs and/or ≥1 bDMARDs were retrospectively evaluated.
- \-
Exclusion
- Patients who could not tolerate the treatment and whose follow-up results could not be reached were excluded from the study.
- \-
Key Trial Info
Start Date :
June 1 2015
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 30 2019
Estimated Enrollment :
35 Patients enrolled
Trial Details
Trial ID
NCT04674085
Start Date
June 1 2015
End Date
December 30 2019
Last Update
December 19 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.